ClinicalTrials.gg
CompletedNCT05915936Updated Jun 23, 2023

LVMR Versus PSR for External FTRPin Elderly Patients

An observational study in Rectal Prolapse, sponsored by Zagazig University. Completed. Open to participants aged 61 Years and older. Per ClinicalTrials.gov, last updated 2023-06-23.

Sponsored by Zagazig University · Observational

Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
330
Ages
61 Years and older
Sex
All
01

Study summary

In frail patients with external full-thickness rectal prolapse (FTRP), the exact postoperative recurrence and functional result outcomes difference between Laparoscopic ventral mesh rectopexy (LVMR) and perineal stapler resection (PSR) have not been investigated, leading to ineffective treatment.

Objectives: Evaluating the efficacy of PSR versus LVMR for treating external FTRP in the elderly.

Design: This was a retrospective study that involved multiple centers. Settings: This study was conducted in the colorectal surgical units of our Universities' Hospitals Patients: 330 elderly patients divided into LVMR group (250), and PSR (80) between April 2012 and April 2019. Before and after surgery, patients were evaluated using the Wexner Incontinence Scale, the Altomare Constipation Scale, and the patient's satisfaction.

Main outcomes measurement: The primary outcome was the recurrence rate and risk factors of FTRP. Secondary outcomes were postoperative incontinence and constipation and patients' satisfaction.

Read the detailed description

From March 2012 to March 2019, 330 frail Patients were evaluated retrospectively using a prospectively collected database in the colorectal surgical divisions of our universities' hospitals. Eligible patients were complete external FTRP (grade 5 according to Oxford prolapse) only or with ODS or FI secondary to FTRP, ≥ 60 years, both sex, ASA-Score I-III, and completed at least four-years follow-up. Exclusion criteria were \< 60 years, incomplete medical records, concurrent colorectal procedures, multi-compartmental prolapse requiring combined operations, open abdominal rectopexy, megacolon, pregnancy, inflammatory bowel disease, unfit for general anesthesia, recurrent rectal prolapse, prior anal surgery, patients under systemic steroid therapy, connective tissue disease, abnormal thyroid function, prior pelvic surgery, diverticulosis/stricture of the colon, previous colorectal resectional surgery, neurological disease, connective tissue disorders, psychiatric disorders, Chronic opioid use.

Outcome Definitions and Measurements:

The primary outcome focused on RP incidence and risk factors. Secondary outcomes included postoperative FI, ODS, and patient satisfaction. Recurrence entailed the presence of recurrent FTRP during follow-up, determined by physical examination and additional imaging. Continence status relied on the Jorge-Wexner grading scale , encompassing five items with a total score ranging from 0(complete continence) to 20 (complete incontinence). To assess ODS, the Altomare score uses 8 Likert scales for a maximum of 31 points for severe constipation []. Postoperative morbidity was assessed by Clavien and Dindo classification []. The measurement of external FTRP was obtained by assessing the distance between the distal margin of the rectum and the anal margin during straining. Anal stenosis was defined as the narrowing of the orifice, characterized by the inability of a 12-mm colonoscopy or the passage of one finger through the constricted opening. [].

02

Conditions studied

  • Rectal Prolapse

Browse trials for

03

In context

Rectal Prolapse

55 studies on the registry are indexed under Rectal Prolapse; 12 are open to participants now.

This study's enrollment of 330 is above the median of 200 across 21 observational studies indexed under Rectal Prolapse.

Browse Rectal Prolapse studies →

Lead sponsor

Zagazig University is the lead sponsor of 459 studies on the registry; 77 are open to participants now.

Of its 5 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
61 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

elderly patients with complete FTRP

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • complete external FTRP (grade 5 according to Oxford prolapse) only or with ODS or FI secondary to FTRP,
  • ≥ 60 years,
  • both sex,
  • ASA-Score I-III, and
  • completed at least four-years follow-up

Exclusion criteria

Exclusion Criteria:

  • \< 60 years,
  • incomplete medical records,
  • concurrent colorectal procedures,
  • multi-compartmental prolapse requiring combined operations,
  • open abdominal rectopexy
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
330 participants (actual)
Patient registry
No

Groups and cohorts

  • laparoscopic ventral mesh rectopexy

    correction of rectal prolapse through laparoscopic ventral mesh rectopexy

    Procedure: LVMR

  • perineal stapler resection

    correction of rectal prolapse through perineal stapler resection

    Procedure: PSR

Interventions

  • ProcedureLVMR

    laoparoscopic ventral mesh rectopexy

  • ProcedurePSR

    perineal stapler resection

06

What researchers measure

Primary outcomes

  1. recurrent rate of rectal prolapse

    % of recurrence after surgery

    Time frame: 4 years

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Apr 2012 to primary completion in Apr 2019, 84 months.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 7, 2023
First posted
Jun 23, 2023
StartActual
Apr 1, 2012
Primary completionActual
Apr 1, 2019
CompletionActual
Apr 1, 2023
Last update
Jun 23, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 23, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05915936
Lead sponsor
Zagazig University
Responsible party
Tamer.A.A.M.Habeeb (professour of general and laparoscopic surgery, Zagazig University) — Principal investigator
First posted
Jun 23, 2023
Start date
Apr 1, 2012
Primary completion
Apr 1, 2019
Completion
Apr 1, 2023
Last update
Jun 23, 2023

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion